Glimepiride Impurity 17 | CAS 850429-04-8 - Request Quote
Glimepiride Impurity 17
| SZ CAT No: | SZ-G008036 |
| CAS No | 850429-04-8 |
| Mol.F. | C8H13NO3 |
| Mol.Wt. | 171.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Glimepiride Impurity 17 is chemically Methyl 3-cyano-2-ethyl-3-hydroxybutanoate. Glimepiride Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Glimepiride Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Glimepiride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 850429-04-8
Purchase 850429-04-8
Order 850429-04-8
Enquire 850429-04-8
price of 850429-04-8
850429-04-8 Supplier
850429-04-8 Manufacturer
850429-04-8 Exporter
buy high quality Glimepiride Impurity 17
Purchase Glimepiride Impurity 17
Glimepiride Impurity 17 suppliers
Glimepiride Impurity 17 manufacturers
Glimepiride Impurity 17 price
Order Glimepiride Impurity 17
Enquire Glimepiride Impurity 17
Glimepiride Impurity 17 cost
Glimepiride Impurity 17 Supplier
Glimepiride Impurity 17 Distributor
Glimepiride Impurity 17 for Method Validation
Glimepiride Reference Standard
Glimepiride Impurity 17 for ANDA Filing
Glimepiride Impurity 17 for Forced Degradation Studies
Glimepiride Impurity 17 Identification Standards
Glimepiride Impurity 17 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.